Paroxysmal cold hemoglobinuria successfully treated with complement inhibition

•This is the first-ever demonstration of successful treatment of paroxysmal cold hemoglobinuria using the complement inhibitor eculizumab.

Saved in:
Bibliographic Details
Published inBlood advances Vol. 3; no. 22; pp. 3575 - 3578
Main Authors Lau-Braunhut, Sarah A., Stone, Hannah, Collins, Griffin, Berentsen, Sigbjørn, Braun, Benjamin S., Zinter, Matt S.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 26.11.2019
American Society of Hematology
Elsevier
Subjects
Exceptional Case Report
Online AccessGet full text

Cover

More Information
Summary:•This is the first-ever demonstration of successful treatment of paroxysmal cold hemoglobinuria using the complement inhibitor eculizumab.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
B.S.B. and M.S.Z. contributed equally and share last authorship.
For data sharing, e-mail corresponding author Sarah A. Lau-Braunhut (sarah.lau-braunhut@ucsf.edu).
ISSN:2473-9529
2473-9537
DOI:10.1182/bloodadvances.2019000897